2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)
TransThera Sciences (Nanjing) Inc.
health
TransThera Sciences (Nanjing) Inc.
State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company